Light at end of the tunnel for Pharmaniaga?
AirAsia X seeks fresh capital post-PN17, sees promising 2024
AAX to bounce back with strong Q4 results, says Maybank IB
AAX appeals to exit PN17 status
Ireka gets 6-month extension to submit PN17 regularisation plan
KNM seeks one-year extension to submit PN17 regularisation plan
Duopharma gets extension for govt hospital contract
AAX’s shares plunge 20% after PN17 upliftment bid rejected
Duopharma not at risk from Pharmaniaga’s PN17 predicament
KNM to dispose loss-making FBM Hudson for RM110mil
Serba Dinamik’s FY2023 net loss widens to RM1.3bil
Comintel to exit PN17 status following financial regularisation
Serba Dinamik kemuka rayuan batal dinyah senarai
Serba Dinamik submits appeal to Bursa Securities against de-listing